Adenovirus infections in transplant recipients

被引：239
作者：
Ison, MG [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Transplant Infect Dis Serv, Chicago, IL 60611 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2006年 / 43卷 / 03期
关键词：
D O I：
10.1086/505498
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Adenoviruses are increasingly recognized as contributors to morbidity and mortality among stem cell and solid-organ transplant recipients. Clinical presentations range from asymptomatic viremia to respiratory and gastrointestinal disease, hemorrhagic cystitis, and severe disseminated illness. The limited clinical data available support the use of cidofovir for many of these illnesses. Prospective studies are needed to better understand the pathogenesis of and therapeutic options for adenoviral infections in this patient population.
引用
收藏
页码：331 / 339
页数：9
相关论文
共 146 条
[1]   Oral ribavirin for severe adenovirus infection after allogeneic marrow transplantation [J].
Abe, S ;
Miyamura, K ;
Oba, T ;
Terakura, S ;
Kasai, M ;
Kitaori, K ;
Sasaki, T ;
Kodera, Y .
BONE MARROW TRANSPLANTATION, 2003, 32 (11) :1107-1108
[2]  
ABKEN H, 1987, ANTICANCER RES, V7, P553
[3]   COMPARISON OF DETECTION METHODS FOR ADENOVIRUS FROM ENTERIC CLINICAL SPECIMENS [J].
AHLUWALIA, GS ;
SCOTTTAYLOR, TH ;
KLISKO, B ;
HAMMOND, GW .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 18 (03) :161-166
[4]   Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation [J].
Akiyama, H ;
Kurosu, T ;
Sakashita, C ;
Inoue, T ;
Mori, S ;
Ohashi, K ;
Tanikawa, S ;
Sakamaki, H ;
Onozawa, Y ;
Chen, Q ;
Zheng, HY ;
Kitamura, T .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) :1325-1330
[5]   Selective depletion of donor alloreactive T cells without loss of antiviral or antileukernic responses [J].
Amrolia, PJ ;
Muccioli-Casadei, G ;
Yvon, E ;
Huls, H ;
Sili, U ;
Wieder, ED ;
Bollard, C ;
Heslop, HE ;
Molldrem, JJ ;
Rooney, CM ;
Brenner, MK .
BLOOD, 2003, 102 (06) :2292-2299
[6]  
Anderson D J, 1990, Semin Respir Infect, V5, P38
[7]   Fatal disseminated adenoviral infection in a renal transplant patient [J].
Ardehali, H ;
Volmar, K ;
Roberts, C ;
Forman, M ;
Becker, LC .
TRANSPLANTATION, 2001, 71 (07) :998-999
[8]   Incidence and outcome of Adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab [J].
Avivi, I ;
Chakrabarti, S ;
Milligan, DW ;
Waldmann, H ;
Hale, G ;
Osman, H ;
Ward, KN ;
Fegan, CD ;
Yong, K ;
Goldstone, AH ;
Limb, DC ;
MacKinnon, S .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (03) :186-194
[9]   Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation [J].
Baldwin, A ;
Kingman, H ;
Darville, M ;
Foot, ABM ;
Grier, D ;
Cornish, JM ;
Goulden, N ;
Oakhill, A ;
Pamphilon, DH ;
Steward, CG ;
Marks, DI .
BONE MARROW TRANSPLANTATION, 2000, 26 (12) :1333-1338
[10]  
Berho M, 1998, Pediatr Transplant, V2, P277
12345678910